DE69804169D1 - Oral anzuwendende flüssige Arzneilösung - Google Patents

Oral anzuwendende flüssige Arzneilösung

Info

Publication number
DE69804169D1
DE69804169D1 DE69804169T DE69804169T DE69804169D1 DE 69804169 D1 DE69804169 D1 DE 69804169D1 DE 69804169 T DE69804169 T DE 69804169T DE 69804169 T DE69804169 T DE 69804169T DE 69804169 D1 DE69804169 D1 DE 69804169D1
Authority
DE
Germany
Prior art keywords
oral liquid
medicinal solution
liquid medicinal
weight
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69804169T
Other languages
English (en)
Other versions
DE69804169T2 (de
Inventor
Roger Edward Tully
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rosemont Group Ltd
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Application granted granted Critical
Publication of DE69804169D1 publication Critical patent/DE69804169D1/de
Publication of DE69804169T2 publication Critical patent/DE69804169T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69804169T 1997-06-27 1998-06-23 Oral anzuwendende flüssige Arzneilösung Expired - Lifetime DE69804169T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201964 1997-06-27

Publications (2)

Publication Number Publication Date
DE69804169D1 true DE69804169D1 (de) 2002-04-18
DE69804169T2 DE69804169T2 (de) 2002-08-29

Family

ID=8228492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69804169T Expired - Lifetime DE69804169T2 (de) 1997-06-27 1998-06-23 Oral anzuwendende flüssige Arzneilösung

Country Status (8)

Country Link
US (1) US6127425A (de)
EP (1) EP0893121B1 (de)
JP (1) JPH1171269A (de)
AT (1) ATE214269T1 (de)
DE (1) DE69804169T2 (de)
DK (1) DK0893121T3 (de)
ES (1) ES2174388T3 (de)
PT (1) PT893121E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
US6541367B1 (en) * 2000-01-18 2003-04-01 Applied Materials, Inc. Very low dielectric constant plasma-enhanced CVD films
FR2910317B1 (fr) * 2006-12-21 2009-02-13 Philippe Perovitch Forme galenique pour l'administration par voie transmuqueuse de paracetamol
KR101025498B1 (ko) * 2008-05-02 2011-03-31 (주)이엘티사이언스 염산브롬헥신 경구용 액제 복합조성물 및 그 제조방법
WO2012142029A2 (en) 2011-04-10 2012-10-18 Florida A&M University Serms for the treatment of estrogen receptor-mediated disorders
ITUA20162292A1 (it) * 2016-04-05 2017-10-05 Gb Pharma S R L Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE293263C (de) *
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
GB8604528D0 (en) * 1986-02-24 1986-04-03 Ici Plc Therapeutic agents
DD293263A5 (de) * 1990-03-23 1991-08-29 Adw,Zi Fuer Molekularbiologie,De Mittel zur hemmung des tumorwachstums
GB9126209D0 (en) * 1991-12-10 1992-02-12 Orion Yhtymae Oy Drug formulations for parenteral use
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
DE4335876A1 (de) * 1993-10-17 1995-04-20 Schering Ag Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics

Also Published As

Publication number Publication date
DE69804169T2 (de) 2002-08-29
PT893121E (pt) 2002-06-28
US6127425A (en) 2000-10-03
EP0893121B1 (de) 2002-03-13
ES2174388T3 (es) 2002-11-01
DK0893121T3 (da) 2002-06-17
EP0893121A1 (de) 1999-01-27
ATE214269T1 (de) 2002-03-15
JPH1171269A (ja) 1999-03-16

Similar Documents

Publication Publication Date Title
SE8505112D0 (sv) Novel pharmacological compounds
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
NO870241L (no) Hypoglykemiske tiazolidindioner.
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
SE8402551L (sv) Cinnamoylmoranolin-derivat
ATE64306T1 (de) Mittel zur erhoehung der transdermalen permeation.
KR890016966A (ko) 신규 항바이러스제
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
DE69804169D1 (de) Oral anzuwendende flüssige Arzneilösung
HUP0402549A2 (hu) Parenterális paracetamol készítmény
KR880007060A (ko) 제약 조성물
DE69531736D1 (de) Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
JPS5781409A (en) External plaster
KR830004849A (ko) 약학적 제제의 제조방법
IT1187743B (it) Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
JPS5762221A (en) Embrocation for external use
KR920019349A (ko) 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도
JPS5762220A (en) Embrocation for external use
SE8104675L (sv) Farmacevtisk komposition med antiflogistisk, antipyretisk och analgetisk verkan
JPS57206609A (en) Solution for external use
JPS56161324A (en) Anti-inflammatory and pain-killing gel
JPS5688758A (en) Chewing gum containing dextranase and its production
JPS54105237A (en) Analgesic agent containing nalorphine-6-glucuronide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SAVIENT PHARMACEUTICALS, INC., EAST BRUNSWICK, N.J

8327 Change in the person/name/address of the patent owner

Owner name: SAVIENT PHARMA HOLDINGS,INC., WILMINGTON, DEL., US

8327 Change in the person/name/address of the patent owner

Owner name: ROSEMONT GROUP LTD., LEEDS, GB